Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Cash from Investing Activities (2021 - 2025)

Invivyd's (IVVD) quarterly Cash from Investing Activities came in at -$11000.0 in Q2 2025, up 92.36% quarter-over-quarter from -$144000.0 in Q1 2025.

Analysis

Invivyd (IVVD) Cash from Investing Activities (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has reported Cash from Investing Activities for 5 consecutive years, with -$11000.0 the latest figure, recorded in Q2 2025.

  • For the quarter ending Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$11000.0; the trailing twelve-month figure through Dec 2025 stood at -$155000.0 (down 10.71% YoY), and the FY2025 full-year result was -$155000.0, down 10.71% from the prior year.
  • Cash from Investing Activities grew to -$11000.0 in Q2 2025 per IVVD's latest filing, from -$144000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $137.9 million in Q4 2021 and bottomed at -$188.6 million in Q3 2021.
  • Historically, Cash from Investing Activities has averaged -$65933.3 across 5 years, with a median of -$5000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities slumped 200.65% in 2022, then jumped 191835.29% in 2023.
  • Over 5 years, Cash from Investing Activities stood at $137.9 million in 2021, then plunged by 200.65% to -$138.8 million in 2022, then jumped by 156.13% to $77.9 million in 2023, then slumped by 99.99% to $5000.0 in 2024, then tumbled by 320.0% to -$11000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$11000.0, -$144000.0, and $5000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -569.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -10.35 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -45.80 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -92.70 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 329.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -363.46 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -3.84 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 24.51 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -11,000.00
Mar 31, 2025 -144,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 -5,000.00
Mar 31, 2024 -140,000.00
Dec 31, 2023 77.92 Mn
Sep 30, 2023 95.14 Mn
Jun 30, 2023 32.60 Mn
Mar 31, 2023 75.04 Mn
Dec 31, 2022 -138.81 Mn
Sep 30, 2022 -140.84 Mn
Jun 30, 2022 -17,000.00
Mar 31, 2022 49.00 Mn
Dec 31, 2021 137.92 Mn
Sep 30, 2021 -188.63 Mn